p21活化激酶4在非小细胞肺癌中的表达及其临床意义  

Expression and clinical significance of PAK4 in non-small cell lung cancer

作　　者：李冬霞[1] 张慧[2] 蔡松旺[3] 

机构地区：[1]新乡医学院基础医学院,河南新乡453003 [2]新乡医学院药学院,河南新乡453003 [3]中山大学附属第三医院胸外科,广东广州510630

出　　处：《中国病理生理杂志》2015年第11期1956-1960,共5页Chinese Journal of Pathophysiology

基　　金：广东省科技计划(No.2012B031800063);广东省卫生厅基金资助项目(No.B2012111)

摘　　要：目的:探讨p21活化激酶4(PAK4)在人非小细胞肺癌细胞系及人非小细胞肺癌组织中的表达及其临床意义。方法:采用Western blot及实时荧光定量PCR检测人支气管上皮(HBE)细胞、非小细胞肺癌细胞(A549、NCI-H520、NCI-H460和NCI-H596细胞)、20例新鲜非小细胞肺癌组织及相应的癌旁组织中PAK4的表达情况;采用免疫组化检测210例非小细胞肺癌组织PAK4的表达情况;采用Kaplan-Meier法评估非小细胞肺癌患者术后5年生存率;用Cox比例风险模型分析PAK4对患者预后的影响。结果:非小细胞肺癌细胞(A549、NCI-H520、NCI-H460和NCI-H596细胞)PAK4蛋白及mRNA表达均显著高于HBE细胞(P<0.05);20例非小细胞肺癌组织中PAK4蛋白及mRNA表达高于癌旁组织PAK4蛋白及mRNA表达(P<0.05);10例转移性非小细胞肺癌组织PAK4 mRNA表达显著高于10例原发性非小细胞肺癌组织(P<0.05);免疫组化染色结果示210例非小细胞肺癌PAK4评分显著高于对应的癌旁组织。临床资料分析显示PAK4蛋白表达与非小细胞肺癌的分化程度、淋巴结转移、远处转移及临床分期有关(P<0.05);PAK4高表达组患者5年生存率显著低于PAK4蛋白低表达组患者(logrank检验,P<0.05),PAK4蛋白表达是非小细胞肺癌患者的独立预后因素。结论:PAK4蛋白高表达是非小细胞肺癌患者死亡的独立危险因素。AIM： To investigate the expression and clinical significance of PAK4 in the cell lines and tissues of non-small cell lung cancer （NSCLC）. METHODS： PAK4 expression in human bronchial epithelial （HBE） cells, NSCLC cell lines, NSCLC tissues and adjacent non-tumor tissues were assessed by immunohistochemistry, real-time PCR and Western blot. Prognostic value of PAK4 expression was evaluated by Kaplan-Meier analysis and Cox regression. RE- SULTS ： PAK4 was over-expressed in the NSCLC cell lines at both mRNA and protein levels compared with HBE cells （ P 〈0. 05）. PAK4 was over-expressed in the NSCLC tissues at both mRNA and protein levels compared with adjacent non- tumor tissues （P 〈 0. 05）. PAK4 was over-expressed in the metastatie NSCLC tissues compared with the primary NSCLC tissues （P 〈 0. 05）. Higher PAK4 staining scores were positively correlated with differentiation, lymph node metastasis, distant metastasis, and clinical stage. Kaplan-Meier analysis and log-rank test showed that overall survival was significantly different between the patients with up-regulated PAK4 and the patients with down-regulated PAK4 （ P 〈 0. 05 ）. PAK4 over- expression was assoeiated with NSCLC progression. CONCLUSION： Inereased PAK4 expression was associated with tumor invasion, metastasis and prognosis in the patients with NSCLC. PAK4 is an important prognostic marker and potential ther- apeutic target in NSCLC.

关 键 词：非小细胞肺癌 p21活化激酶4 预后 

分 类 号：R734.2[医药卫生—肿瘤] R730.23[医药卫生—临床医学]